Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00602186

Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Sponsor: Tabriz University

Updated 5 times since 2017 Last updated: Jan 26, 2008 Started: Jul 31, 2005 Primary completion: Mar 31, 2007 Completion: Mar 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00602186, this PHASE1/PHASE2 trial focuses on Neurogenic Bladder and remains ongoing. Sponsored by Tabriz University, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Jul 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tabriz University

Data source: Tabriz University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.